SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-025231
Filing Date
2023-07-21
Accepted
2023-07-21 16:02:27
Documents
18
Period of Report
2023-07-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 57478
2 ex1-1.htm EX-1.1 212057
3 ex5-1.htm EX-5.1 11739
4 ex99-1.htm EX-99.1 13608
5 ex5-1_002.jpg GRAPHIC 11356
6 ex99-1_001.jpg GRAPHIC 16080
  Complete submission text file 0001493152-23-025231.txt   607271

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE hrow-20230718.xsd EX-101.SCH 3944
8 XBRL DEFINITION FILE hrow-20230718_def.xml EX-101.DEF 26962
9 XBRL LABEL FILE hrow-20230718_lab.xml EX-101.LAB 37183
10 XBRL PRESENTATION FILE hrow-20230718_pre.xml EX-101.PRE 25582
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6087
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 231102552
SIC: 2834 Pharmaceutical Preparations